WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein, Tamir; Patsopoulos, Nikolaos A; Weiser, Mark.
Cochrane Database Syst Rev
; (5): CD005041, 2016 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-27228176
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Long-Term Tolerability and Safety of Pharmacological Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A 6-Year Prospective Naturalistic Study.
Lens opacities in children using methylphenidate hydrochloride.
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Pharmacological interventions for apathy in Alzheimer's disease.
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial.
ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.